GW Henssler & Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$533K Sell
2,869
-179
-6% -$33.2K 0.03% 127
2025
Q1
$639K Buy
3,048
+1,814
+147% +$380K 0.04% 112
2024
Q4
$244K Sell
1,234
-61
-5% -$12K 0.01% 142
2024
Q3
$256K Sell
1,295
-796
-38% -$157K 0.01% 141
2024
Q2
$359K Sell
2,091
-162,032
-99% -$27.8M 0.02% 113
2024
Q1
$29.9M Sell
164,123
-2,696
-2% -$491K 1.76% 17
2023
Q4
$25.9M Sell
166,819
-2,391
-1% -$371K 1.71% 15
2023
Q3
$25.2M Sell
169,210
-1,982
-1% -$295K 1.72% 16
2023
Q2
$23.1M Sell
171,192
-708
-0.4% -$95.4K 1.51% 25
2023
Q1
$27.4M Sell
171,900
-2,566
-1% -$409K 1.82% 10
2022
Q4
$28.2M Sell
174,466
-983
-0.6% -$159K 1.98% 10
2022
Q3
$23.5M Buy
175,449
+668
+0.4% +$89.7K 1.76% 16
2022
Q2
$26.8M Sell
174,781
-1,170
-0.7% -$179K 1.99% 11
2022
Q1
$28.5M Buy
175,951
+837
+0.5% +$136K 1.73% 14
2021
Q4
$23.7M Buy
175,114
+855
+0.5% +$116K 1.51% 17
2021
Q3
$18.8M Buy
174,259
+1,931
+1% +$208K 1.3% 30
2021
Q2
$19.4M Buy
172,328
+2,738
+2% +$308K 1.28% 29
2021
Q1
$18.4M Buy
169,590
+6,505
+4% +$704K 1.31% 32
2020
Q4
$17.5M Sell
163,085
-1,424
-0.9% -$153K 1.34% 28
2020
Q3
$14.4M Buy
164,509
+3,468
+2% +$304K 1.22% 34
2020
Q2
$15.8M Buy
161,041
+15,145
+10% +$1.49M 1.39% 33
2020
Q1
$11.1M Buy
+145,896
New +$11.1M 1.13% 45
2015
Q2
Sell
-3,495
Closed -$205K 165
2015
Q1
$205K Hold
3,495
0.02% 163
2014
Q4
$229K Sell
3,495
-123
-3% -$8.06K 0.03% 146
2014
Q3
$209K Sell
3,618
-333
-8% -$19.2K 0.03% 135
2014
Q2
$223K Sell
3,951
-1,845
-32% -$104K 0.03% 131
2014
Q1
$298K Buy
5,796
+77
+1% +$3.96K 0.04% 134
2013
Q4
$302K Buy
5,719
+38
+0.7% +$2.01K 0.04% 130
2013
Q3
$254K Sell
5,681
-439
-7% -$19.6K 0.03% 130
2013
Q2
$253K Buy
+6,120
New +$253K 0.03% 128